Would you like to know how many people have read this article? Or how reputable the author is? Simply
sign up for a Advocate premium membership and you'll automatically see this data on every article. Plus a lot more, too.
Perhaps the initial panic selling of Monogram Biosciences stock this morning shouldn't be surprising. Monogram manufactures a diagnostic test used to identify HIV patients who would respond to Pfizer's maraviroc drug, which didn't get the expected FDA approval on June 20.